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Disruption of endothelial integrity is an essential component of vascular inflammation, 
angiogenesis, atherosclerosis, and tumor metastasis. Many studies have shown that activation of 
myosin light chain kinase (MLCK) in endothelial cell is correlated with increase in vascular 
permeability. Currently, most research in endothelial cells has focused on the 220kDa MLCK 
isoform which is the predominant isoform present in cultured endothelial cells. However, in freshly 
isolated uncultured endothelial cells, the 130kDa MLCK predominates. Yet nothing is known 
about the roles of the 130kDa MLCK isoform in endothelial cells. Therefore, our goal is to 
determine the role of the 130kDa MLCK in regulating vascular permeability and angiogenesis in 
vivo. To do this we will generate an endothelial cell-specific 130kDa MLCK knockout mice. As 
transcripts encoding the 130 and 220kDa MLCK isoforms are produced by independent 
promoters within the same mylk1 gene, I will selectively knockout the 130kDa MLCK by deleting 
unique cis-acting gene regulatory elements required for the expression of this transcript. A key 
element identified within the intron following the first exon of the 130kDa MLCK transcript has 
been flanked by LoxP sites such that Cre recombinase (Cre) mediated recombination will delete 
the element and attenuate expression of the 130kDa MLCK. By crossing these floxed mice with 
Tie2-Cre mice which express Cre specifically in endothelial cells, I will obtain endothelial cell-
specific 130kDa MLCK knockout mice. In vivo vascular permeability and angiogenesis assays on 
these mice will allow me to determine the role played by the 130kDa MLCK in these processes. 
This study will not only help to identify specific functions of the 130kDa MLCK isoform, but also 
determine if this is a drug target for developing novel treatments of vascular diseases and cancer. 
